Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Matter

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Angewandte Chemie (International Ed. in English)|June 3, 2015
Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative PropertiesHolger Hoffmann, Herbert Kogler, Winfried Heyse, et al.
Chemmedchem|November 1, 2018
The Role of Bridging Water and Hydrogen Bonding as Key Determinants of Noncovalent Protein-Carbohydrate RecognitionAnatoly M Ruvinsky, Ishita Aloni, Daniel Cappel, et al.
European Journal of Pharmacology|March 26, 2013
Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1)Marc D Voss, Gerhard Zoller, Hans Matter, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligandMarc Nazaré, Melanie Essrich, David W Will, et al.
Journal of Medicinal Chemistry|July 8, 2005
Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallographyMarc Nazaré, David W Will, Hans Matter, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituentsMarc Nazaré, Melanie Essrich, David W Will, et al.
International Journal of Emergency Medicine|July 12, 2013
State of Emergency Medicine in Switzerland: a national profile of emergency departments in 2006Bienvenido Sanchez, Alexandre H Hirzel, Roland Bingisser, et al.
Journal of Medicinal Chemistry|June 14, 2002
Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor XaHans Matter, Elisabeth Defossa, Uwe Heinelt, et al.
Journal of Medicinal Chemistry|July 22, 2005
Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthasesHans Matter, H S Arun Kumar, Roman Fedorov, et al.
Nature Communications|May 13, 2022
Molecular basis for inhibiting human glucose transporters by exofacial inhibitorsNan Wang, Shuo Zhang, Yafei Yuan, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|June 3, 2015
Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative PropertiesHolger Hoffmann, Herbert Kogler, Winfried Heyse, et al.
Chemmedchem|November 1, 2018
The Role of Bridging Water and Hydrogen Bonding as Key Determinants of Noncovalent Protein-Carbohydrate RecognitionAnatoly M Ruvinsky, Ishita Aloni, Daniel Cappel, et al.
European Journal of Pharmacology|March 26, 2013
Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1)Marc D Voss, Gerhard Zoller, Hans Matter, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligandMarc Nazaré, Melanie Essrich, David W Will, et al.
Journal of Medicinal Chemistry|July 8, 2005
Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallographyMarc Nazaré, David W Will, Hans Matter, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituentsMarc Nazaré, Melanie Essrich, David W Will, et al.
International Journal of Emergency Medicine|July 12, 2013
State of Emergency Medicine in Switzerland: a national profile of emergency departments in 2006Bienvenido Sanchez, Alexandre H Hirzel, Roland Bingisser, et al.
Journal of Medicinal Chemistry|June 14, 2002
Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor XaHans Matter, Elisabeth Defossa, Uwe Heinelt, et al.
Journal of Medicinal Chemistry|July 22, 2005
Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthasesHans Matter, H S Arun Kumar, Roman Fedorov, et al.
Nature Communications|May 13, 2022
Molecular basis for inhibiting human glucose transporters by exofacial inhibitorsNan Wang, Shuo Zhang, Yafei Yuan, et al.
Pageof 7